patient study treatment trial disease drug subject event risk diagnosis analysis month year follow using dose case medication death compared diabetes pet diagnostic time cohort laboratory use high adverse day performed infection age indication one however imaging cardiac surgery discharge randomized increased post rate primary additional due cardiovascular renal assessed 
clinical therapy reported hospital outcome related cancer site organ result blood dialysis included heart considered table data group based baseline associated guideline procedure clinical_trial treated protocol type mortality acute versus without used symptom received population low transplant phase kidney admission surgical efficacy expected survival pre following stage disorder medical difference 



